Tower Research Capital LLC (TRC) - TALARIS THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of TALARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,703
+16793.8%
962
-88.9%
0.00%
-100.0%
Q1 2023$16
+77.8%
8,666
-4.1%
0.00%
Q4 2022$9
-100.0%
9,034
+4.6%
0.00%
Q3 2022$23,000
+53.3%
8,637
+156.4%
0.00%
Q2 2022$15,000
-81.0%
3,369
-58.0%
0.00%
-100.0%
Q1 2022$79,000
+618.2%
8,013
+1031.8%
0.00%
Q4 2021$11,000
+10.0%
708
-9.8%
0.00%
Q3 2021$10,000
+900.0%
785
+1166.1%
0.00%
Q2 2021$1,000620.00%
Other shareholders
TALARIS THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 2,932,606$8,240,62310.94%
BML Capital Management, LLC 2,000,000$5,620,0005.16%
Nantahala Capital Management 2,953,129$8,298,2920.71%
GREAT POINT PARTNERS LLC 1,000,000$2,810,0000.51%
Acuitas Investments, LLC 194,547$546,6770.32%
Affinity Asset Advisors, LLC 400,000$1,124,0000.32%
RA Capital Management 2,403,238$6,753,0990.13%
Artal Group S.A. 914,262$2,5690.11%
Blackstone Inc. 8,089,315$22,730,9750.10%
QVT Financial LP 589,314$1,655,9720.09%
View complete list of TALARIS THERAPEUTICS INC shareholders